至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Epidemiological, Clinical and Genetic Study of Hypophosphatasia in A Spanish Population: Identification of Two Novel Mutations in The Alpl Gene.

Sci Rep. 2019-07; 
García-FontanaCristina,Villa-SuárezJuan M,Andújar-VeraFrancisco,González-SalvatierraSheila,Martínez-NavajasGonzalo,RealPedro J,Gómez VidaJosé M,de HaroTomás,García-FontanaBeatriz,Muñoz-TorresMa
Products/Services Used Details Operation
Custom Vector Construction The pcDNA3.1+ vector containing the full-length wild type (WT) ALPL gene was obtained from GenScript company (Clone ID: OHu23066). Get A Quote

摘要

Hypophosphatasia (HPP) is a genetic disease caused by one or several mutations in ALPL gene encoding the tissue-nonspecific alkaline phosphatase affecting the mineralization process. Due to its low prevalence and lack of recognition, this metabolic disorder is generally confused with other more frequent bone disorders. An assessment of serum total alkaline phosphatase (ALP) levels was performed in 78,590 subjects. Pyridoxal-5'-phosphate (PLP) concentrations were determined and ALPL gene was sequenced in patients potentially affected by HPP. Functional validation of the novel mutations found was performed using a cell-based assay. Our results showed persistently low serum ALP levels in 0.12% of subjects. Amo... More

关键词